Phase II study of bevacizumab (Bv) in combination with paclitaxel-carboplatin (PC) as first-line chemotherapy for nonsquamous (SQ) non-small cell lung cancer (NSCLC) with malignant pleural effusion (MPE).
Motohiro Tamiya
No relevant relationships to disclose
Tomonori Hirashima
No relevant relationships to disclose
Akihiro Tamiya
No relevant relationships to disclose
Norio Okamoto
No relevant relationships to disclose
Hidekazu Suzuki
No relevant relationships to disclose
Tadahiro Yamadori
No relevant relationships to disclose
Naoko Morishita
No relevant relationships to disclose
Takayuki Shiroyama
No relevant relationships to disclose
Tomoyuki Otsuka
No relevant relationships to disclose
Kanako Kitai
No relevant relationships to disclose
Tomomi Yasue
No relevant relationships to disclose
Kazuhiro Asami
No relevant relationships to disclose
Shojiro Minomo
No relevant relationships to disclose
Syoko Sonobe
No relevant relationships to disclose
Keiko Nakao
No relevant relationships to disclose
Tomoya Kawaguchi
No relevant relationships to disclose
Shinji Atagi
No relevant relationships to disclose
Ichiro Kawase
No relevant relationships to disclose